Our findings are consistent with prior reports indicating that increased XBP1s protein levels can predict NSCLC aggressiveness32, and that IRE1α is prognostic of recurrence in resected NSCLC patients33. This evidence concerns the gene ERN1 and non-small cell lung carcinoma.